Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Operating Expenses history
Currency unavailable · from the income statement
No Operating Expenses data reported for this period type.
Operating Expenses vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $767.6M USD | +21.3% | +57.1% | 1081.7% | |
| LTM Jun 2026 | $250.97M USD | +6.0% | +32.7% | 3524.4% | |
| FY2025 | $95.43M USD | — | — | 512.6% | |
| LTM Mar 2026 | $86.18M USD | -19.9% | -10.1% | 38304.0% | |
| LTM Mar 2026 | $55.59M USD | +44.8% | +41.8% | — | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | +13.7% | +37.2% | 2303.0% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.